Quarterly report · Q3
6960.TEDINET S100Q3IX
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥93.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥132.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥93.1bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥16.1bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥15.9bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥16.8bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥23.4bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.3bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥16.9bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥16.8bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥16.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.6bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥11.6bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥195.2bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥195.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥183.2bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥38.6bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥45.6bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥156.6bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥149.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥145.2bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥63.3bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥64.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥383.71 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥115.28 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥536.19 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥382.89 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥135.08 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 80.2% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥25.5bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥25.5bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥40.5bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥40.5bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.9bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥20.0bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥20.0bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥93.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥93.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥16.1bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥24.5bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥24.5bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥3.4bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥40.4bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥40.4bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥8.5bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥18.8bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥18.8bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥93.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥93.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥15.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 372
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Operating income | Prior1YTDDuration | 15863000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember | 19973000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember | 7490000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember | 40534000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember | 25483000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 93481000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 93481000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember | 19973000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember | 7490000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember | 40534000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember | 25483000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 93481000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Net sales | CurrentYTDDuration | 93481000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember | 3000000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember | 1245000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember | 8929000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember | 2902000000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 16077000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Operating income | CurrentYTDDuration | 16077000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-02-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第76期第3四半期(自 2022年10月1日 至 2022年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)フクダ電子株式会社 | |
| Company name in english cover page | FilingDateInstant | FUKUDA DENSHI CO., LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 白井 大治郎 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都文京区本郷三丁目39番4号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)(03)3815-2121(大代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)社長室経理部長 本部 晴彦 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都文京区本郷三丁目39番4号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)(03)3815-2121(大代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)社長室経理部長 本部 晴彦 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02304 | |
| Fund code | FilingDateInstant | - | |
| Security code | FilingDateInstant | 69600 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)フクダ電子株式会社 | |
| Filer name in english | FilingDateInstant | FUKUDA DENSHI CO., LTD. |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |